Tokyo Tape
Sign in
← Muromachi Chemicals

Quarterly report · Q3

4885.TEDINET S100QLE5
Period2022-06-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 38
MetricValuePeriodScopeSource row
Revenue¥4.6bn2022-06-01 → 2023-02-28StandaloneNet sales
Revenue¥5.7bn2021-06-01 → 2022-05-31StandaloneNet sales (5-year summary)
Revenue¥4.1bn2021-06-01 → 2022-02-28StandaloneNet sales
Operating income¥325m2022-06-01 → 2023-02-28StandaloneOperating income
Operating income¥355m2021-06-01 → 2022-02-28StandaloneOperating income
Ordinary income¥309m2022-06-01 → 2023-02-28StandaloneOrdinary income
Ordinary income¥423m2021-06-01 → 2022-05-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥355m2021-06-01 → 2022-02-28StandaloneOrdinary income
Profit before tax¥309m2022-06-01 → 2023-02-28StandaloneIncome before income taxes
Profit before tax¥354m2021-06-01 → 2022-02-28StandaloneIncome before income taxes
Net income¥230m2022-06-01 → 2023-02-28StandaloneProfit loss
Net income¥456m2021-06-01 → 2022-05-31StandaloneNet income loss (5-year summary)
Net income¥300m2021-06-01 → 2022-02-28StandaloneProfit loss
Total assets¥5.0bnat 2023-02-28StandaloneAssets
Total assets¥4.8bnat 2022-05-31StandaloneAssets
Total assets¥4.6bnat 2022-02-28StandaloneTotal assets (5-year summary)
Total liabilities¥3.1bnat 2023-02-28StandaloneLiabilities
Total liabilities¥3.1bnat 2022-05-31StandaloneLiabilities
Net assets / equity¥1.9bnat 2023-02-28StandaloneNet assets
Net assets / equity¥1.7bnat 2022-05-31StandaloneNet assets
Net assets / equity¥1.6bnat 2022-02-28StandaloneNet assets (5-year summary)
Cash and deposits¥681mat 2023-02-28StandaloneCash and deposits
Cash and deposits¥865mat 2022-05-31StandaloneCash and deposits
EPS (basic)¥61.462022-06-01 → 2023-02-28StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥21.532022-12-01 → 2023-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥123.792021-06-01 → 2022-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥81.552021-06-01 → 2022-02-28StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥10.262021-12-01 → 2022-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥58.552022-06-01 → 2023-02-28StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥112.562021-06-01 → 2022-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥73.622021-06-01 → 2022-02-28StandaloneDiluted earnings per share (5-year summary)
Dividend per share¥192021-06-01 → 2022-05-31StandaloneDividend paid per share (5-year summary)
Equity ratio37.5%at 2023-02-28StandaloneEquity to asset ratio (5-year summary)
Equity ratio35.0%at 2022-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio35.2%at 2022-02-28StandaloneEquity to asset ratio (5-year summary)
Shares issued4,095,500at 2023-02-28StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2022-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2022-02-28StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥1.5bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥1.5bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentsegment profit2022-06-01 → 2023-02-28−¥25m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥528m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥528m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentsegment profit2022-06-01 → 2023-02-28−¥75m
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥2.6bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥2.6bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2022-06-01 → 2023-02-28¥426m
—segment totalrevenue2022-06-01 → 2023-02-28¥4.6bn
—segment totalrevenue external2022-06-01 → 2023-02-28¥4.6bn
—segment totalsegment profit2022-06-01 → 2023-02-28¥325m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-02-28¥4.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-02-28¥4.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-02-28¥325m
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue2021-06-01 → 2022-02-28¥1.4bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue external2021-06-01 → 2022-02-28¥1.4bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentsegment profit2021-06-01 → 2022-02-28−¥2m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue2021-06-01 → 2022-02-28¥668m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue external2021-06-01 → 2022-02-28¥668m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentsegment profit2021-06-01 → 2022-02-28¥22m
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue2021-06-01 → 2022-02-28¥2.0bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2021-06-01 → 2022-02-28¥2.0bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2021-06-01 → 2022-02-28¥335m
—segment totalrevenue2021-06-01 → 2022-02-28¥4.1bn
—segment totalrevenue external2021-06-01 → 2022-02-28¥4.1bn
—segment totalsegment profit2021-06-01 → 2022-02-28¥355m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2022-02-28¥4.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2022-02-28¥4.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2022-02-28¥355m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 369
ItemContextValueUnit
Treasury stockCurrentQuarterInstant_NonConsolidatedMember-102746000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember1671415000JPY
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember1854339000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember9664000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant_NonConsolidatedMember16784000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember9664000JPY
Valuation and translation adjustmentsCurrentQuarterInstant_NonConsolidatedMember16784000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember1681080000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember1871123000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember4798071000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember4993241000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember4087743000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember4624606000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember2787602000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember3300480000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember1300140000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember1324125000JPY
Salaries and allowances sgaPrior1YTDDuration_NonConsolidatedMember337664000JPY
Salaries and allowances sgaCurrentYTDDuration_NonConsolidatedMember336774000JPY
Legal welfare expenses sgaPrior1YTDDuration_NonConsolidatedMember76597000JPY
Legal welfare expenses sgaCurrentYTDDuration_NonConsolidatedMember77904000JPY
Provision for bonuses sgaPrior1YTDDuration_NonConsolidatedMember74669000JPY
Provision for bonuses sgaCurrentYTDDuration_NonConsolidatedMember79069000JPY
Retirement benefit expenses sgaPrior1YTDDuration_NonConsolidatedMember10867000JPY
Retirement benefit expenses sgaCurrentYTDDuration_NonConsolidatedMember11542000JPY
Share based compensation expenses sgaPrior1YTDDuration_NonConsolidatedMember2216000JPY
Share based compensation expenses sgaCurrentYTDDuration_NonConsolidatedMember7761000JPY
Provision for directors retirement benefits sgaPrior1YTDDuration_NonConsolidatedMember9300000JPY
Provision for directors retirement benefits sgaCurrentYTDDuration_NonConsolidatedMember－JPY
Other sgaPrior1YTDDuration_NonConsolidatedMember434054000JPY
Other sgaCurrentYTDDuration_NonConsolidatedMember485664000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember945368000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember998715000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember354771000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember325409000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember0JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember27000JPY
Dividends income noiPrior1YTDDuration_NonConsolidatedMember792000JPY
Dividends income noiCurrentYTDDuration_NonConsolidatedMember781000JPY
Foreign exchange gains noiPrior1YTDDuration_NonConsolidatedMember6425000JPY
Foreign exchange gains noiCurrentYTDDuration_NonConsolidatedMember－JPY
Subsidy income noiPrior1YTDDuration_NonConsolidatedMember－JPY
Subsidy income noiCurrentYTDDuration_NonConsolidatedMember851000JPY
Insurance fee income noiPrior1YTDDuration_NonConsolidatedMember3611000JPY
Insurance fee income noiCurrentYTDDuration_NonConsolidatedMember5405000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember2815000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember2481000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember13647000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember9546000JPY
Interest expenses noePrior1YTDDuration_NonConsolidatedMember12869000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2022-05-31pass rounding
balance sheet identitynon_consolidated 2023-02-28pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-05-31pass
statement vs summary · net assetsnon_consolidated 2023-02-28pass
statement vs summary · revenuenon_consolidated 2021-06-01/2022-02-28pass
statement vs summary · revenuenon_consolidated 2022-06-01/2023-02-28pass
statement vs summary · total assetsnon_consolidated 2022-05-31pass
statement vs summary · total assetsnon_consolidated 2023-02-28pass